Laryngopharyngeal reflux (LPR) has been linked to a variety of inflammatory conditions in the laryngopharynx, including vocal process granuloma, subg lottic stenos is, polyp oid corditis, and laryn geal carcinoma.1. 2 Aggressive antireflux treatment has been shown to diminish laryn geal signs of inflamm ation (e.g., erythema and edema), ' and it is considered to be the prim ary treatment for LPR; digital laryngovideostrob oscopy has demonstrated that a 6-wee k course of twic e-d aily proton-pump inhib itor (PP!) therap y lessens the effects of LPR .4 In additio n, a limited amount of data has show n that antireflux treatm ent can also lead to a reversal or resolution of voca l fold epithelial changes such as dyspl asia and hyperkeratosis (Ja mie A. Koufman , MD ; person al commun ication , 2002) . In fac t, our ex per ience includes a case ofbiopsy-p roved voca l fold epith elial dysplasia and hyp erkeratosis that resolved over a 2-year course of PPI therapy.
Figure. Panel ofvideolaryngostroboscopic still images shows how the left vocalfo ld leukoplakia resolved over the 2-year period.
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Our patient was a 71-year-old man who had been referred to our clinic for evaluation of a 2-year history of persistent voca l fold leukoplakia. Th e lesion , which had been initially biop sied at another facility, was made up of hyperpl astic and reacti ve squamous epithelium with mild dyspla sia. It had recurred within 4 weeks of the previous biopsy. Upon presentation to our clinic, the patient co mplained of worse ning dysphon ia, a strai ned voice, excessive throat mucus, and throat clearing. Of note, he had a 45-to 60-pac k/year smok ing history, but he had quit smoking I month ea rlier.
Th e initial video laryngos trobosco py showed that the leukoplakia was co nfined to the anter ior half of the left voca l fold ( figure) . Th e mucosal wave was absent in the area of the lesion , and the amplitude was severely diminished . Posterior laryngiti s and pseud osulcus were present , sugges ting the pre senc e of LPR . The patien t was started on a twic e-da ily proton-pump inhibitor and was followed every month stroboscopically. As treatment continued, he experienced a gradual improvement in his voice and in the appearance of the leukoplakia ( figure ) . At 2 years, the dyspla stic lesion had disappeared ( figure) . In addi tion, his vibratory function and mucosal pliabil ity were restored , and the mucosa l wave had fully returned. At 2Y2 yea rs, the patie nt showed no sig n of recurrence of the leukoplakia.
BECAUSE YOUR PATIENTS COME IN ALL SHAPES AND SIZES.
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LPR may be a cofactor in the developme nt of dysplastic and premalign ant changes in the laryngeal epitheliu m. When it is, PPI treatment ca n lead to a reversal of voca l fold leukoplakia and/or epit helial dysp lasia in carefully selected patient s-that is, in those wit h coexisting pseud osulcus or interarytenoid eryt hema or ede ma." Malignancy should be exc luded prior to medically treatin g a suspec ted dysp lastic vocal fold lesion. I
